Medical Xpress January 31, 2025
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure. This was compared to usual treatment with a beta-blocker according to a new study from the University of Birmingham, the city where digoxin was first used in 1785.
In a paper published in the journal Heart, researchers conducted an economic analysis on a clinical trial called RATE-AF to look at the differences between two widely used drugs for older patients with a common heart rhythm disorder called atrial fibrillation (AF) and symptoms of heart failure.
The RATE-AF trial included 160 patients and randomly assigned them to receive digoxin or beta-blockers for 12...
Today's Sponsors
Today's Sponsor